These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3522723)

  • 1. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
    Friedli A; De Grandi P
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
    Brügger D; Dreher E
    Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
    Somell C; Olund A
    Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervical dilatation by use of a vaginal suppository of meteneprost before voluntary interruption of the pregnancy in the first trimester].
    Maria B; André-David F; Oury JF; Stampf F; Bresson E; Rosenberg P
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):637-42. PubMed ID: 3668189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a new vaginal suppository: prostaglandin E1 analog Gemeprost for cervix maturation prior to abortion in the 1st trimester].
    Rabe T; Helk J; Kiesel L; Zwick J; Runnebaum B
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):393-401. PubMed ID: 3894147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
    Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
    Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH; Graves ZR
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
    Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
    Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double blind study of a new ready-for use prostaglandin gel (Org 2436) for cervical ripening prior to first trimester pregnancy termination.
    Osmers R; Rath W; Conrad A; Kuhn W
    Zentralbl Gynakol; 1990; 112(9):545-54. PubMed ID: 2378185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
    Sidhu MS; Kent DR
    Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
    Shapiro AG; Lasseter K; Cobiella A; Domenzain M
    Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
    Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical dilatation in the nonpregnant patient with vaginal 16-dimethyl prostaglandin E2.
    Nuss RC; Baird T; Benrubi G; Thompson RJ
    J Fla Med Assoc; 1985 Jun; 72(6):426-7. PubMed ID: 4045400
    [No Abstract]   [Full Text] [Related]  

  • 16. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
    Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
    Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
    Christensen NJ; Bygdeman M
    Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
    Hald F; Kristoffersen SE; Gregersen E
    Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cervix-ripening effect of 15-methyl-prostaglandin F2 alpha methyl ester before vacuum aspiration for termination of early pregnancy in primigravidae.
    Wang YF; Jin YC; Wu YE; Gu LJ; Xie XH
    Chin Med J (Engl); 1989 Mar; 102(3):200-2. PubMed ID: 2503307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.